Aimmune Therapeutics Inc.https://investorshangout.com/Aimmune-Therapeutics-Inc-AIMT-92983/en-usSun, 13 Sep 2026 16:17:25 GMTCopyright InvestorsHangout.comznewcar1: AIMT 171% v44,6M c34.22 f65,4Mhttps://investorshangout.com/post/view?id=5879953https://investorshangout.com/post/view?id=5879953Mon, 31 Aug 2020 20:24:24 GMTwhytestocks: $AIMT News Article - ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Aimmune Therapehttps://investorshangout.com/post/view?id=5879522https://investorshangout.com/post/view?id=5879522Mon, 31 Aug 2020 16:15:47 GMTwhytestocks: $AIMT News Article - (AIMT) Alert: Johnson Fistel Investigates Proposed Sale of Aimmune Therapeuticshttps://investorshangout.com/post/view?id=5879304https://investorshangout.com/post/view?id=5879304Mon, 31 Aug 2020 14:05:46 GMTwhytestocks: $AIMT News Article - Aimmune Therapeutics Enters Definitive Agreement with Soci t s des Produits Neshttps://investorshangout.com/post/view?id=5879291https://investorshangout.com/post/view?id=5879291Mon, 31 Aug 2020 14:00:47 GMTwhytestocks: $AIMT short squeeze article https://investorshangout.com/post/view?id=5607909https://investorshangout.com/post/view?id=5607909Tue, 03 Dec 2019 14:25:46 GMTwhytestocks: $AIMT News Article - Quality of Life Outcomes from Two New Surveys Highlight Emotional Impact of Peahttps://investorshangout.com/post/view?id=5587259https://investorshangout.com/post/view?id=5587259Fri, 08 Nov 2019 18:20:42 GMTwhytestocks: $AIMT News Article - New Real-World Data Unveiled at ACAAI Indicates Comparable Clinical Practice Lohttps://investorshangout.com/post/view?id=5587209https://investorshangout.com/post/view?id=5587209Fri, 08 Nov 2019 17:45:52 GMTwhytestocks: $AIMT News Article - Here's Why Aimmune Therapeutics Stock Is Surging Today https://investorshangout.com/post/view?id=5536441https://investorshangout.com/post/view?id=5536441Wed, 11 Sep 2019 19:45:44 GMTwhytestocks: $AIMT News Article - Aimmune to Present AR101 Data at European Academy of Allergy and Clinical Immunhttps://investorshangout.com/post/view?id=5445545https://investorshangout.com/post/view?id=5445545Fri, 24 May 2019 14:55:40 GMTwhytestocks: $AIMT News Article - New Study Shows More Than Half of Teens with Peanut Allergy Visited the E.R., Mhttps://investorshangout.com/post/view?id=5442652https://investorshangout.com/post/view?id=5442652Tue, 21 May 2019 20:15:40 GMTwhytestocks: $AIMT News Article - Aimmune Therapeutics to Present at 18th Annual Needham & Company Healthcare Conhttps://investorshangout.com/post/view?id=5402386https://investorshangout.com/post/view?id=5402386Wed, 03 Apr 2019 17:30:41 GMTwhytestocks: $AIMT News Article - European Phase 3 Trial of Aimmune Therapeutics' AR101 Meets Primary Endpoint https://investorshangout.com/post/view?id=5391507https://investorshangout.com/post/view?id=5391507Mon, 25 Mar 2019 16:05:45 GMT